Systematic review of optical coherence tomography usage in the diagnosis and management of basal cell carcinoma

British Journal of Dermatology

Volumn 173, Issue 6, 2015, Pages 1371-1380

  Cheng, H M ^a   Guitera, P ^b  

^a MELANOMA INSTITUTE AUSTRALIA   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; IMIQUIMOD;

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; OPTICAL COHERENCE TOMOGRAPHY; PATIENT CARE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TREATMENT PLANNING; ADULT; AGED; CARCINOMA, BASAL CELL; MALE; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; PROCEDURES; SKIN NEOPLASMS; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84983128426     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.14042     Document Type: Review

References (60)

1. Olsen CM, Williams PF, Whiteman DC,. Turning the tide? Changes in treatment rates for keratinocyte cancers in Australia 2000 through 2011. J Am Acad Dermatol 2014; 71: 21-6.e1.
2. Fransen M, Karahalios A, Sharma N, et al,. Non-melanoma skin cancer in Australia. Med J Aust 2012; 197: 565-8.
3. Staples MP, Elwood M, Burton RC, et al,. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006; 184: 6-10.
4. Ortel B, Maytin EV,. Progress in dermatology. Photonics Lasers Med 2013; 2: 265-7.
5. Drakaki E, Vergou T, Dessinioti C, et al,. Spectroscopic methods for the photodiagnosis of nonmelanoma skin cancer. J Biomed Opt 2013; 18: 061221.
6. Dasgeb B, Kainerstorfer J, Mehregan D, et al,. An introduction to primary skin imaging. Int J Dermatol 2013; 52: 1319-30.
7. Calin MA, Parasca SV, Savastru R, et al,. Optical techniques for the noninvasive diagnosis of skin cancer. J Cancer Res Clin Oncol 2013; 139: 1083-104.
8. Gambichler T, Jaedicke V, Terras S,. Optical coherence tomography in dermatology: technical and clinical aspects. Arch Dermatol Res 2011; 303: 457-73.
9. Emer JJ, Markowitz O,. Trends in the treatment and detection of skin cancer. J Drugs Dermatol 2011; 10: 16-18.
10. Mogensen M, Thrane L, Jorgensen TM, et al,. OCT imaging of skin cancer and other dermatological diseases. J Biophotonics 2009; 2: 442-51.
11. Mogensen M, Jemec GBE,. Diagnosis of nonmelanoma skin cancer/keratinocyte carcinoma: a review of diagnostic accuracy of nonmelanoma skin cancer diagnostic tests and technologies. Dermatol Surg 2007; 33: 1158-74.
12. Ulrich M, Stockfleth E, Roewert-Huber J, Astner S,. Noninvasive diagnostic tools for nonmelanoma skin cancer. Br J Dermatol 2007; 157 (Suppl. 2): 56-8.
13. Happe M, Freitag M, Stucker M, et al,. [ High resolution 20 MHz ultrasound diagnosis in dermatology for noninvasive imaging of malignant melanomas]. Z Arztl Fortbild Qualitatssich 1997; 91: 347-53 (in German).
14. Wilder-Smith P, Jung W-G, Brenner M, et al,. In vivo optical coherence tomography for the diagnosis of oral malignancy. Lasers Surg Med 2004; 35: 269-75.
15. Hussain A, Themstrup L, Jemec G,. Conventional and high-definition optical coherence tomography in the diagnosis of basal cell carcinoma: a systematic review. Br J Dermatol 2014; 171: e82.
16. Steiner R, Kunzi-Rapp K, Scharffetter-Kochanek K,. Optical coherence tomography: clinical applications in dermatology. Med Laser Appl 2003; 18: 249-59.
17. Hamdoon Z, Jerjes W, Upile T, Hopper C,. Optical coherence tomography-guided photodynamic therapy for skin cancer: case study. Photodiagnosis Photodyn Ther 2011; 8: 49-52.
18. Korde VR, Bonnema GT, Xu W, et al,. Using optical coherence tomography to evaluate skin sun damage and precancer. Lasers Surg Med 2007; 39: 687-95.
19. Pierce MC, Strasswimmer J, Park BH, et al,. Advances in optical coherence tomography imaging for dermatology. J Invest Dermatol 2004; 123: 458-63.
20. Jensen LK, Thrane L, Andersen PE, et al,. Optical coherence tomography in clinical examinations of nonpigmented skin malignancies. Proc SPIE OSA Biomed Optics 2003; 5140: 160-7.
21. Gambichler T, Valavanis K, Plura I, et al,. In vivo determination of epidermal thickness using high-definition optical coherence tomography. Br J Dermatol 2014; 170: 737-9.
22. Anderson RR, Kulesz-Martin MF,. Montagna symposium 2013-light and skin: how light sustains, damages, treats, images and modifies skin biology. J Invest Dermatol 2014; 134: 2064-7.
23. Wortsman X,. Sonography of facial cutaneous basal cell carcinoma: a first-line imaging technique. J Ultrasound Med 2013; 32: 567-72.
24. Picard A, Tsilika K, Long-Mira E, et al,. Use of high-definition optical coherent tomography (HD-OCT) for imaging of melanoma. Br J Dermatol 2013; 169: 950-2.
25. Chen WL, Hu PS, Ghazaryan A, et al,. Quantitative analysis of multiphoton excitation autofluorescence and second harmonic generation imaging for medical diagnosis. Comput Med Imaging Graph 2012; 36: 519-26.
26. Harland C,. Mirror, mirror on the wall. How photodamaged am I? Br J Dermatol 2011; 165: 707.
27. Arndt KA, Rohrer TE,. Introduction to the laser journal. Lasers Surg Med 2011; 43: 63-4.
28. Forsea AM, Carstea EM, Ghervase L, et al,. Clinical application of optical coherence tomography for the imaging of non-melanocytic cutaneous tumors: a pilot multi-modal study. J Med Life 2010; 3: 381-9.
29. von Elm E, Altman DG, Egger M, et al,. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ 2007; 85: 867-72.
30. Hoogedoorn L, Peppelman M, Kerkhof P, et al,. The value of in vivo reflectance confocal microscopy in monitoring and diagnosis of inflammatory and infectious skin diseases: a systematic review. Br J Dermatol 2015; 172: 1222-48.
31. Mogensen M, Joergensen TM, Nürnberg BM, et al,. Assessment of optical coherence tomography imaging in the diagnosis of non-melanoma skin cancer and benign lesions versus normal skin: observer-blinded evaluation by dermatologists and pathologists. Dermatol Surg 2009; 35: 965-72.
32. Jørgensen TM, Tycho A, Mogensen M, et al,. Machine-learning classification of non-melanoma skin cancers from image features obtained by optical coherence tomography. Skin Res Tech 2008; 14: 364-9.
33. Ulrich M, von Braunmuehl T, Kurzen H, et al,. The sensitivity and specificity of optical coherence tomography for the assisted diagnosis of nonpigmented basal cell carcinoma: an observational study. Br J Dermatol 2015; 173: 428-35.
34. Coleman AJ, Penney GP, Richardson TJ, et al,. Automated registration of optical coherence tomography and dermoscopy in the assessment of sub-clinical spread in basal cell carcinoma. Comput Aided Surg 2014; 19: 1-12.
35. Wang KX, Meekings A, Fluhr JW, et al,. Optical coherence tomography-based optimization of Mohs micrographic surgery of basal cell carcinoma: a pilot study. Dermatol Surg 2013; 39: 627-33.
36. Alawi SA, Kuck M, Wahrlich C, et al,. Optical coherence tomography for presurgical margin assessment of non-melanoma skin cancer-a practical approach. Exp Dermatol 2013; 22: 547-51.
37. Derpalyuka EN, Gladkova ND, Petrova GA, et al,. Optical coherence tomography for diagnosis and guided surgery of basal cell carcinoma. In: Saratov Fall Meeting 2004: Optical Technologies in Biophysics and Medicine VI. Proceedings of the Society of Photo-Optical Instrumentation Engineers (SPIE) (, Tuchin VV, ed). Bellingham, WA: SPIE, 2005; 103-7.
38. Chan CS, Rohrer TE,. Optical coherence tomography and its role in Mohs micrographic surgery: a case report. Case Rep Dermatol 2012; 4: 269-74.
39. Pomerantz R, Zell D, McKenzie G, Siegel DM,. Optical coherence tomography used as a modality to delineate basal cell carcinoma prior to Mohs micrographic surgery. Case Rep Dermatol 2011; 3: 212-18.
40. Pelosini L, Smith HB, Schofield JB, et al,. In vivo optical coherence tomography (OCT) in periocular basal cell carcinoma: correlations between in vivo OCT images and postoperative histology. Br J Ophthalmol 2013; 97: 890-4.
41. Cunha D, Richardson T, Sheth N, et al,. Comparison of ex vivo optical coherence tomography with conventional frozen-section histology for visualizing basal cell carcinoma during Mohs micrographic surgery. Br J Dermatol 2011; 165: 576-80.
42. Maier T, Kulichova D, Ruzicka T, et al,. Ex vivo high-definition optical coherence tomography of basal cell carcinoma compared to frozen-section histology in micrographic surgery: a pilot study. J Eur Acad Dermatol Venereol 2014; 28: 80-5.
43. Durkin JR, Fine JL, Sam H, et al,. Imaging of Mohs micrographic surgery sections using full-field optical coherence tomography: a pilot study. Dermatol Surg 2014; 40: 367-74.
44. Mogensen M, Nürnberg BM, Forman JL, et al,. In vivo thickness measurement of basal cell carcinoma and actinic keratosis with optical coherence tomography and 20-MHz ultrasound. Br J Dermatol 2009; 160: 1026-33.
45. Hinz T, Ehler LK, Hornung T, et al,. Preoperative characterization of basal cell carcinoma comparing tumour thickness measurement by optical coherence tomography, 20-MHz ultrasound and histopathology. Acta Derm Venereol 2012; 92: 132-7.
46. Olmedo JM, Warschaw KE, Schmitt JM, Swanson DL,. Correlation of thickness of basal cell carcinoma by optical coherence tomography in vivo and routine histologic findings: a pilot study. Dermatol Surg 2007; 33: 421-5.
47. Coleman AJ, Richardson TJ, Orchard G, et al,. Histological correlates of optical coherence tomography in non-melanoma skin cancer. Skin Res Technol 2013; 19: 10-19.
48. Themstrup L, Banzhaf CA, Mogensen M, Jemec GBE,. Optical coherence tomography imaging of non-melanoma skin cancer undergoing photodynamic therapy reveals subclinical residual lesions. Photodiagnosis Photodyn Ther 2014; 11: 7-12.
49. Banzhaf CA, Themstrup L, Ring HC, et al,. Optical coherence tomography imaging of non-melanoma skin cancer undergoing imiquimod therapy. Skin Res Technol 2014; 20: 170-6.
50. Clark C, Markowitz O,. Confirmation of non-melanoma skin cancer clearance using optical coherence tomography imaging. Lasers Surg Med 2013; 45: 281.
51. Ulrich M, Maier T, Kurzen H, et al,. Multicentre study evaluating the sensitivity and specificity of optical coherence tomography for the diagnosis of basal cell carcinoma. Br J Dermatol 2014; 171 (Suppl. 4): 8.
52. Bennàssar A, Vilata A, Puig S, Malvehy J,. Ex vivo fluorescence confocal microscopy for fast evaluation of tumour margins during Mohs surgery. Br J Dermatol 2014; 170: 360-5.
53. Longo C, Rajadhyaksha M, Ragazzi M, et al,. Evaluating ex vivo fluorescence confocal microscopy images of basal cell carcinomas in Mohs excised tissue. Br J Dermatol 2014; 171: 561-70.
54. Marmur ES, Berkowitz EZ, Fuchs BS, et al,. Use of high-frequency, high-resolution ultrasound before Mohs surgery. Dermatol Surg 2010; 36: 841-7.
55. Desai TD, Desai AD, Horowitz DC, et al,. The use of high-frequency ultrasound in the evaluation of superficial and nodular basal cell carcinomas. Dermatol Surg 2007; 33: 1220-7.
56. Mogensen M, Nüurnberg BM, Thrane L, et al,. How histological features of basal cell carcinomas influence image quality in optical coherence tomography. J Biophotonics 2011; 4: 544-51.
57. Maier T, Kulichova D, Ruzicka T, Berking C,. Noninvasive monitoring of basal cell carcinomas treated with systemic hedgehog inhibitors: pseudocysts as a sign of tumor regression. J Am Acad Dermatol 2014; 71: 725-30.
58. Strasswimmer J, Pierce MC, Park BH, et al,. Polarization-sensitive optical coherence tomography of invasive basal cell carcinoma. J Biomed Optics 2004; 9: 292-8.
59. Themstrup L, Banzhaf C, Ring HC, et al,. Optical coherence tomography monitoring of NMSC undergoing photodynamic therapy. Skin Res Technol 2013; 19: e558.
60. Banzhaf C, Themstrup L, Ring HC, et al,. Optical coherence tomography of NMSC undergoing imiquimod therapy. Skin Res Technol 2013; 19: e569.